Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PMS-IRBESARTAN-HCTZ 12.5MG 150MG TABLET Resolved 2017-03-24 2018-04-27 4213
PMS-IRBESARTAN-HCTZ 12.5MG 150MG TABLET Resolved 2019-06-11 2019-09-04 86225
PMS-IRBESARTAN-HCTZ 12.5MG 150MG TABLET Resolved 2019-06-28 2020-09-18 87959
PMS-IRBESARTAN-HCTZ 12.5MG 150MG TABLET Resolved 2022-11-11 2023-03-30 174390
PMS-IRBESARTAN-HCTZ 12.5MG 300MG TABLET Resolved 2017-03-24 2017-09-19 4216
PMS-IRBESARTAN-HCTZ 12.5MG 300MG TABLET Resolved 2021-11-15 2023-04-06 149254
PMS-IRBESARTAN-HCTZ 25MG 300MG TABLET Resolved 2017-04-20 2017-06-09 7373
PMS-IRBESARTAN-HCTZ 25MG 300MG TABLET Resolved 2017-06-23 2017-12-18 13709
PMS-IRBESARTAN-HCTZ 25MG 300MG TABLET Resolved 2017-09-07 2018-03-20 21562
PMS-IRBESARTAN-HCTZ 25MG 300MG TABLET Resolved 2019-06-28 2019-12-24 87971

Showing 441 to 450 of 678

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2018-09-07 2019-02-13 60521
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO TRIAZIDE 50MG 25MG TABLET Discontinued 2018-09-08 2019-02-13 60837
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-10 2018-12-28 60997
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
ACT CANDESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65050
ACT CANDESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65052

Showing 41 to 50 of 102